Clinical trialNCT03331198RecruitingPhase 1/PHASE2Interventional

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

SponsorJuno Therapeutics, a Subsidiary of CelgeneEnrollment320Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Small Lymphocytic

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

84 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Local Institution - 0112
Toronto, Ontario, Canada

United States

Local Institution - 0006
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
Local Institution - 0043
Gilbert, Arizona, United States
City of Hope
Duarte, California, United States
Local Institution - 0007
Duarte, California, United States
Local Institution - 0025
La Jolla, California, United States
Uc San Diego Moores Cancer Center
La Jolla, California, United States
Local Institution - 0059
Los Angeles, California, United States
University of California, Los Angeles
Los Angeles, California, United States
Local Institution - 0010
San Francisco, California, United States
University of California, San Francisco
San Francisco, California, United States
Local Institution - 0111
Denver, Colorado, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
Local Institution - 0085
Washington D.C., District of Columbia, United States
Local Institution - 0080
Jacksonville, Florida, United States
Mayo Clinic
Jacksonville, Florida, United States
Local Institution - 0019
Atlanta, Georgia, United States
Local Institution - 0104
Atlanta, Georgia, United States
the Blood and Marrow Transplant Group of Georgia (bmtga)
Atlanta, Georgia, United States
Local Institution - 0003
Chicago, Illinois, United States
Local Institution - 0016
Chicago, Illinois, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Local Institution - 0105
Indianapolis, Indiana, United States
Local Institution - 0107
Wichita, Kansas, United States
Local Institution - 0064
Louisville, Kentucky, United States
Local Institution - 0027
New Orleans, Louisiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Local Institution - 0005
Boston, Massachusetts, United States
Local Institution - 0015
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Local Institution - 0084
Ann Arbor, Michigan, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Local Institution - 0062
Detroit, Michigan, United States
Local Institution - 0109
Detroit, Michigan, United States
Local Institution - 0054
Rochester, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States

44 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

JCAR017JCAR017 + ibrutinibJCAR017 + venetoclax

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Nov 2017
Primary completion: 26 Nov 2027
Completion: 26 Nov 2027
Last update posted: 6 Jul 2026
Registered enrollment: 320
Registry id: NCT03331198

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.